1. Home
  2. ATRA vs ALOT Comparison

ATRA vs ALOT Comparison

Compare ATRA & ALOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRA
  • ALOT
  • Stock Information
  • Founded
  • ATRA 2012
  • ALOT 1969
  • Country
  • ATRA United States
  • ALOT United States
  • Employees
  • ATRA N/A
  • ALOT N/A
  • Industry
  • ATRA Biotechnology: Biological Products (No Diagnostic Substances)
  • ALOT Computer peripheral equipment
  • Sector
  • ATRA Health Care
  • ALOT Technology
  • Exchange
  • ATRA Nasdaq
  • ALOT Nasdaq
  • Market Cap
  • ATRA 67.9M
  • ALOT 69.2M
  • IPO Year
  • ATRA 2014
  • ALOT N/A
  • Fundamental
  • Price
  • ATRA $12.29
  • ALOT $11.27
  • Analyst Decision
  • ATRA Strong Buy
  • ALOT
  • Analyst Count
  • ATRA 3
  • ALOT 0
  • Target Price
  • ATRA $21.00
  • ALOT N/A
  • AVG Volume (30 Days)
  • ATRA 65.3K
  • ALOT 4.5K
  • Earning Date
  • ATRA 08-11-2025
  • ALOT 09-15-2025
  • Dividend Yield
  • ATRA N/A
  • ALOT N/A
  • EPS Growth
  • ATRA N/A
  • ALOT N/A
  • EPS
  • ATRA 0.56
  • ALOT N/A
  • Revenue
  • ATRA $188,667,000.00
  • ALOT $156,030,000.00
  • Revenue This Year
  • ATRA N/A
  • ALOT N/A
  • Revenue Next Year
  • ATRA N/A
  • ALOT N/A
  • P/E Ratio
  • ATRA $21.82
  • ALOT N/A
  • Revenue Growth
  • ATRA 202.41
  • ALOT 7.14
  • 52 Week Low
  • ATRA $5.01
  • ALOT $7.53
  • 52 Week High
  • ATRA $18.71
  • ALOT $17.24
  • Technical
  • Relative Strength Index (RSI)
  • ATRA 62.30
  • ALOT 51.14
  • Support Level
  • ATRA $10.32
  • ALOT $11.03
  • Resistance Level
  • ATRA $12.31
  • ALOT $11.99
  • Average True Range (ATR)
  • ATRA 0.90
  • ALOT 0.51
  • MACD
  • ATRA -0.04
  • ALOT -0.05
  • Stochastic Oscillator
  • ATRA 77.93
  • ALOT 59.78

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

Share on Social Networks: